Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Janin

Showing results (271-280 of 290) with videos related to

Pageof 29
Sort By:
Transplantation Proceedings|January 3, 2001
A pilot study of cyclosporine withdrawal in stable renal transplant recipients after azathioprine-mycophenolate mofetil conversionE Thervet, E Morelon, D Ducloux, et al.
The British Journal of Dermatology|February 16, 2007
Inactivation of the CDKN2A and the p53 tumour suppressor genes in external genital carcinomas and their precursorsN Soufir, S Queille, M Liboutet, et al.
Gastroenterology|January 1, 1996
Aberrant expression of a human mucin gene (MUC5AC) in rectosigmoid villous adenomaM P Buisine, A Janin, V Maunoury, et al.
Cancer Gene Therapy|June 19, 2010
The soluble fragment of VE-cadherin inhibits angiogenesis by reducing endothelial cell proliferation and tube capillary formationH Li, X Shi, J Liu, et al.
Leukemia|October 10, 2013
MicroRNA187 overexpression is related to tumor progression and determines sensitivity to bortezomib in peripheral T-cell lymphomaZ-X Yan, L-L Wu, K Xue, et al.
Oncogene|November 17, 2005
Microsatellite instability and mutation analysis of candidate genes in urothelial cell carcinomas of upper urinary tractP Mongiat-Artus, C Miquel, M Van der Aa, et al.
Leukemia|May 22, 2013
Leukemia-initiating cell activity requires calcineurin in T-cell acute lymphoblastic leukemiaS Gachet, E Genescà, D Passaro, et al.
The British Journal of Dermatology|April 3, 2016
KIR3DL2 (CD158k) is a potential therapeutic target in primary cutaneous anaplastic large-cell lymphomaM Battistella, A Janin, F Jean-Louis, et al.
Leukemia|March 14, 2009
The proteasome inhibitor bortezomib interacts synergistically with the histone deacetylase inhibitor suberoylanilide hydroxamic acid to induce T-leukemia/lymphoma cells apoptosisQ-L Zhang, L Wang, Y-W Zhang, et al.
Obesity Science & Practice|November 18, 2025
Six Years of Genetic Diagnosis of Severe Early-Onset Obesity in a French CohortM Rama, E Blond, A Janin, et al.
Pageof 29

Showing results (271-280 of 290) with videos related to

Sort By:
Pageof 29
Transplantation Proceedings|January 3, 2001
A pilot study of cyclosporine withdrawal in stable renal transplant recipients after azathioprine-mycophenolate mofetil conversionE Thervet, E Morelon, D Ducloux, et al.
The British Journal of Dermatology|February 16, 2007
Inactivation of the CDKN2A and the p53 tumour suppressor genes in external genital carcinomas and their precursorsN Soufir, S Queille, M Liboutet, et al.
Gastroenterology|January 1, 1996
Aberrant expression of a human mucin gene (MUC5AC) in rectosigmoid villous adenomaM P Buisine, A Janin, V Maunoury, et al.
Cancer Gene Therapy|June 19, 2010
The soluble fragment of VE-cadherin inhibits angiogenesis by reducing endothelial cell proliferation and tube capillary formationH Li, X Shi, J Liu, et al.
Leukemia|October 10, 2013
MicroRNA187 overexpression is related to tumor progression and determines sensitivity to bortezomib in peripheral T-cell lymphomaZ-X Yan, L-L Wu, K Xue, et al.
Oncogene|November 17, 2005
Microsatellite instability and mutation analysis of candidate genes in urothelial cell carcinomas of upper urinary tractP Mongiat-Artus, C Miquel, M Van der Aa, et al.
Leukemia|May 22, 2013
Leukemia-initiating cell activity requires calcineurin in T-cell acute lymphoblastic leukemiaS Gachet, E Genescà, D Passaro, et al.
The British Journal of Dermatology|April 3, 2016
KIR3DL2 (CD158k) is a potential therapeutic target in primary cutaneous anaplastic large-cell lymphomaM Battistella, A Janin, F Jean-Louis, et al.
Leukemia|March 14, 2009
The proteasome inhibitor bortezomib interacts synergistically with the histone deacetylase inhibitor suberoylanilide hydroxamic acid to induce T-leukemia/lymphoma cells apoptosisQ-L Zhang, L Wang, Y-W Zhang, et al.
Obesity Science & Practice|November 18, 2025
Six Years of Genetic Diagnosis of Severe Early-Onset Obesity in a French CohortM Rama, E Blond, A Janin, et al.
Pageof 29